Biopolymeric delivery matrices for angiogenic growth factors. (Q35589939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

review article

1 reference

title

Biopolymeric delivery matrices for angiogenic growth factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Matthias P Lutolf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andreas H Zisch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

published in

Cardiovascular Pathology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

295-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic angiogenesis in cardiology using protein formulations

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Clinical applications of vascular gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Angiogenesis: initiation and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Polymeric system for dual growth factor delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

The fate of intravenously administered bFGF and the effect of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Protein delivery from materials formed by self-selective conjugate addition reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Alginate based new materials

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Alginate as immobilization matrix for cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Release from alginate enhances the biological activity of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Controlled and modulated release of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Pulsatile drug release control using hydrogels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

A novel approach for studying angiogenesis: a human skin equivalent with a capillary-like network

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Fibrin glue as matrix for cultured autologous urothelial cells in urethral reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Biologic glue increases capillary ingrowth after cardiomyoplasty in an ischemic cardiomyopathy model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Improvement of tracheal autograft revascularization by means of fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Covalently conjugated VEGF--fibrin matrices for endothelialization

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Development of growth factor fusion proteins for cell-triggered drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Development of fibrin derivatives for controlled release of heparin-binding growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Site-directed neovessel formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Skin equivalent produced with human collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Controlled release of vascular endothelial growth factor by use of collagen hydrogels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Bioactive biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Emerging design principles in biomaterials and scaffolds for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Engineering vascular networks in porous polymer matrices

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

The delivery of angiogenic factors to the heart by microsphere therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Development of poly-(D,L-lactide--coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Randomized controlled trial of a synthetic sealant for preventing alveolar air leaks after lobectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Trial of a novel synthetic sealant in preventing air leaks after lung resection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Optimization of photopolymerized bioerodible hydrogel properties for adhesion prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Comparison of covalently and physically cross-linked polyethylene glycol-based hydrogels for the prevention of postoperative adhesions in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Efficacy of a resorbable hydrogel barrier, oxidized regenerated cellulose, and hyaluronic acid in the prevention of ovarian adhesions in a rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Adhesion prevention with ancrod released via a tissue-adherent hydrogel

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Local release of fibrinolytic agents for adhesion prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

Repair of bone defects using synthetic mimetics of collagenous extracellular matrices

1 reference

https://api.crossref.org/works/10.1016%2FS1054-8807%2803%2900089-9

7 January 2021

10.1016/S1054-8807(03)00089-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14630296%20AND%20SRC:MED&resulttype=core&format=json